CANF Intrinsic Valuation and Fundamental Analysis - Can Fite Biopharma Ltd - Alpha Spread

C

Watchlist Manager

Watchlist

Price: 268 ILS -13.13%

Market Cap: ₪11.4m

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Can Fite Biopharma Ltd.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Can Fite Biopharma Does

Biotechnology Health Care

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Headquarters: Israel IL
Employees: 8
IPO date: Sep 22, 2005

Read the full company overview

View Company Overview

Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Jun 2024 Dec 2024 Jun 2025 Dec 2025

Wall St Price Targets

Capital Returns

Buyback Yield

What is Buyback Yield?

Debt Paydown Yield

What is Debt Paydown Yield?

Competitive Landscape

Continue CANF Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 362,400+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.